Zydus Foundation Vice Chairperson Meha Patel appointed as Member of CII National Committee on Art & Culture for 2025-26
Ahmedabad:Zydus Foundation Vice Chairperson Meha Patel has been appointed as Member of CII National Committee on Art & Culture for 2025-26. "We are delighted to announce that our Vice Chairperson, Zydus Foundation, Ms. Meha Patel has been appointed as the Member of CII National Committee on Art & Culture for 2025-26," Zydus shared in a recent LinkedIn Post. Zydus Foundation was incorporated as a section 8 Company under the provisions of the Companies Act, 2013. The main object of the Company is to establish, run, manage and maintain hospitals and educational institutions in rural areas. To serve the needs of the patients and bring medical education to rural interiors of Gujarat, the Company has set up the Zydus Medical College and Hospital at Dahod. The hospital provides free treatment including OPD, indoor, all investigations, surgeries, anesthesia, oral medicines, injectables and food for patients. Zydus Medical College and Hospital Dahod, is a self-financed brownfield medical college project, set up in a Public Private Partnership (PPP) model of Government of Gujarat.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!